AQUINOX PHARMACEUTICALS CANADA INC has a total of 56 patent applications. It increased the IP activity by 16.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and machines are ACHE LABORATORIOS FARM S A, AQUINOX PHARMACEUTICALS (CANADA) INC and WENDER PAUL A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Australia | 8 | |
#4 | Israel | 7 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Mexico | 3 | |
#10 | Brazil | 2 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Harwig Curtis | 40 |
#2 | Raymond Jeffery R | 33 |
#3 | Mackenzie Lloyd F | 29 |
#4 | Pettigrew Jeremy D | 28 |
#5 | Bogucki David | 23 |
#6 | Macrury Thomas B | 16 |
#7 | Seenisamy Jeyaprakashnarayanan | 10 |
#8 | Shan Rudong | 10 |
#9 | Cross Jennifer | 10 |
#10 | Khlebnikov Vladimir | 9 |
Publication | Filing date | Title |
---|---|---|
WO2019195751A1 | Indene derivatives useful in treating pain and inflammation | |
WO2018126040A1 | Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3- (hydroxymethyl)-4-methylcyclohexanol | |
US2018085460A1 | Methods of treating prostatitis | |
AU2017209430A1 | Synthesis of a substituted indene derivative | |
AU2016281658A1 | Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol | |
MX2015012111A | Ship1 modulators and methods related thereto. | |
US2016083387A1 | SHIP1 modulators and methods related thereto |